FDA Orange Book
Is there a generic for Verquvo?
Verquvo contains vericiguat. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Verquvo (vericiguat). The Orange Book shows its last listed patent expires November 26, 2032 and its last listed exclusivity ends January 21, 2029.
Run it in Rivvi
Map Verquvo and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Verquvo products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| tablet, oral | 10MG | Marketed (Rx) | None | 0 | None |
| tablet, oral | 2.5MG | Marketed (Rx) | None | 0 | None |
| tablet, oral | 5MG | Marketed (Rx) | None | 0 | None |
NDA 214377, held by MERCK SHARP AND DOHME LLC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Verquvo patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 9993476 | May 19, 2031 | Method of use | U-3062 | 214377 |
| 8921377 | May 19, 2031 | Method of use | U-3062 | 214377 |
| 11439642 | May 19, 2031 | Method of use | U-3062 | 214377 |
| 10736896 | May 19, 2031 | Drug substance, Drug product | None | 214377 |
| 8420656 | May 19, 2031 | Drug substance, Drug product | None | 214377 |
| 9604948 | November 26, 2032 | Drug substance, Drug product | U-3062 | 214377 |
Verquvo exclusivity
| Code | Meaning | Expires | NDA |
|---|---|---|---|
| NCE | New chemical entity | January 19, 2026 | 214377 |
| D-198 | New dosing schedule | January 21, 2029 | 214377 |
Verquvo NDC codes
Questions
Is there a generic for Verquvo?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Verquvo (vericiguat). The Orange Book shows its last listed patent expires November 26, 2032 and its last listed exclusivity ends January 21, 2029.
What is the generic name for Verquvo?
The active ingredient in Verquvo is vericiguat, per the FDA Orange Book.
When does the Verquvo patent expire?
The last patent listed for Verquvo in the Orange Book expires November 26, 2032. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.